Company Celsion Corporation Nasdaq
Equities
US15117N4043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | Dec. 10 |
Khursheed Anwer
CTO | Chief Tech/Sci/R&D Officer | 64 | 14-06-19 |
Kimberly Bragg
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-10-02 |
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Donald Braun
BRD | Director/Board Member | 74 | 15-12-14 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 21-06-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,811 | 9,291,441 ( 98.85 %) | 22 ( 0.000234 %) | 98.85 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.84% | 103B | |
+1.55% | 95.28B | |
+1.46% | 22.15B | |
-16.16% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.18% | 16.05B | |
+5.52% | 13.68B | |
+33.36% | 12.17B |
- Stock Market
- Equities
- IMNN Stock
- Stock
- Company Celsion Corporation